ClinicalTrials.Veeva

Menu

Hepatic Enzymes, Psychological Measures, and Sexual Dysfunction Responses to Aerobic Exercise in Hepatitis-C Men

Cairo University (CU) logo

Cairo University (CU)

Status

Enrolling

Conditions

Erectile Dysfunction
Hepatitis C

Treatments

Behavioral: exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT05624086
P.T.REC/012/004114

Details and patient eligibility

About

Chronic hepatitis C virus (HCV) infection is a systematic disease that affects several aspects of patients' well-being, including physical, mental, social, and sexual quality of life. In recent years, this clinical trial aims to search the Response of Hepatic Enzymes, Psychological Measures, and Sexual Dysfunction to Aerobic Exercise in Hepatitis Men With Sexual Dysfunction Complaint

Full description

Hepatitis Men With Sexual Dysfunction (erectile dysfunction) Complaint (n=46) will be randomized randomly to 23-men exercise-training (one hour walking on treadmill, for 3 months, three walking sessions per the week) hepatitis-C group or 23-men waiting-hepatitis-C group.

Enrollment

46 estimated patients

Sex

Male

Ages

35 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • men with hepatitis C men diagnosis
  • men with sexual dysfunction (erectile dysfunction)

Exclusion criteria

  • obesity , men with cardiac/thoracic/systemic diseases, drugs for sexual dysfunction (erectile dysfunction)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

46 participants in 2 patient groups

Exercised group
Experimental group
Description:
In this group, Hepatitis-C Men With Sexual Dysfunction (erectile dysfunction) Complaint (n=23) will receive exercise-training sessions (one hour walking on treadmill, for 3 months, three walking sessions per the week)
Treatment:
Behavioral: exercise
control group
No Intervention group
Description:
in this group, Hepatitis-C Men With Sexual Dysfunction (erectile dysfunction) Complaint (n=23) will act as a control (waitlist) group that will receive no trainning

Trial contacts and locations

1

Loading...

Central trial contact

Ali Ismail, lecturer; Ali Ismail, Lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems